SLC2A1 and breast cancer: The present study is the first to use bioinformatics and laboratory experiments to demonstrate that the increased mRNA expression of GLUT1 was also associated with poor prognosis and metastasis in breast cancer, which may be regulated via JUN by binding to GLUT1 promoter.